Stealth Health Acquires Kramer, Expanding Access to Compounded Medications Across Canada

Acquisition marks a major step toward Stealth Health’s fully integrated healthcare ecosystem, connecting telemedicine, prescribing, compounding and delivery.

TORONTO, Oct. 20, 2026 /CNW/ — Stealth Health, a leading North American telemedicine platform focused on longevity, precision wellness and personalized healthcare, today announced that it has completed the acquisition of Kramer, a Canadian company with a nationwide network designed to simplify access to compounded medications.

The acquisition represents a significant milestone in Stealth Health’s strategy to build a fully integrated healthcare ecosystem, bringing together virtual medical consultations, personalized prescribing, specialized pharmaceutical compounding and direct-to-patient medication delivery.

Canadian prescribed compounded medications can face challenges finding a pharmacy equipped to prepare and dispense them. Kramer addresses this gap by connecting retail pharmacies with specialized compounding partners while preserving their patient relationships. Integrating this network with Stealth Health’s platform will create a more direct path from consultation to medication delivery, reducing the burden on patients to navigate the system themselves.

Kramer’s platform offers:

• Nationwide compounding access: Connecting pharmacies across Canada with specialized compounding partners.
• Specialized compounding services: Connecting referring pharmacies with compounding partners to support patients’ individual prescription needs.
• Seamless pharmacy integration: Simplified prescription transfers without complex technology integration or long-term contractual commitments.
• Patient relationship protection: Allowing referring pharmacies to retain their patients while accessing specialized pharmaceutical services.
• Convenient medication delivery: Coordinated dispensing and shipping directly to patients through participating compounding pharmacies.

With the acquisition now completed, Stealth Health plans to further integrate these capabilities into its digital healthcare platform and enterprise white-label network.

Building an End-to-End Healthcare Ecosystem

Adding Kramer’s nationwide compounding network strengthens Stealth Health’s ability to coordinate care from virtual consultation and personalized prescribing through pharmaceutical fulfillment and home delivery. The acquisition supports the company’s broader expansion across North America and its growing portfolio of services in longevity medicine, hormone optimization, weight management, sexual wellness, preventive health and personalized therapeutics.

The combined capabilities will also support Stealth Health’s enterprise white-label partners, helping healthcare organizations, clinics and wellness brands connect virtual care with specialized pharmaceutical fulfillment in Canada.

Executive Commentary

“Our vision is a fully integrated healthcare ecosystem across North America, where telemedicine, prescribing, compounding and delivery work as one,” said Matthew Mazzuca, Chief Executive Officer of Stealth Health. “Kramer is a major step toward that vision. It gives us a nationwide compounding network that pharmacies already trust, and it strengthens our foundation as we continue to expand in longevity, precision wellness and personalized healthcare. Personalized medicine only works if patients can actually get the medication their clinician prescribed, and this acquisition helps make that seamless.”

“This acquisition is about operational depth,” said Phill Whitman, Chief Operating Officer of Stealth Health. “Our enterprise white-label partners have been asking for reliable access to specialized fulfillment in Canada. Kramer gives us an established network of compounding partners and a model that respects the relationship between pharmacies and their patients. We look forward to working with Kramer’s partner pharmacies as we integrate these capabilities.”

“We built Kramer so that no pharmacy has to turn a patient away because a prescription needs compounding,” said David Del Balso, Chief Executive Officer of Kramer. “Joining Stealth Health gives our network the reach and infrastructure to grow faster, while keeping the principle we started with: the patient stays with the pharmacy they trust. We’re excited to bring our partner pharmacies into a broader platform that connects care from the first consultation to the moment a medication arrives at the patient’s door.”

The transaction closed on October 16, 2026. Financial terms were not disclosed.

About Stealth Health

Stealth Health is a leading North American telemedicine platform focused on longevity, precision wellness and personalized healthcare. By connecting virtual care, individualized prescribing, specialized pharmaceutical fulfillment and an enterprise white-label network, Stealth Health is building a fully integrated healthcare ecosystem that improves access to timely, high-quality care across the United States and Canada.

About Kramer

Kramer connects pharmacies across Canada with specialized compounding partners, allowing retail pharmacies to fulfill their patients’ compounded prescriptions without losing the patient. Through a simple prescription transfer model, partner pharmacies compound and ship medications directly to patients, while referring pharmacies retain their patient relationships. Learn more at usekramer.com.

SOURCE Stealth Health

Disclaimer: The above press release comes to you under an arrangement with PR Newswire. NYnewscast.com takes no editorial responsibility for the same.